PI3K/AKT PATHWAY IS INVOLVED IN MDS PATHOGENESIS AND MAY CONSTITUTE A POTENTIAL THERAPEUTIC TARGET

被引:0
|
作者
Rezende, D. C. [1 ]
Pacheco, L. Z. [1 ]
Pelloso, L. A. F. [1 ]
Chauffaille, M. L. L. F. [1 ]
Yamamoto, Y. [1 ]
Silva, M. [2 ]
Kerbauy, D. B. [1 ]
机构
[1] UNIFESP EPM, Sao Paulo, Brazil
[2] HSPE FMO, Serv Hematol, Sao Paulo, Brazil
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
174
引用
收藏
页码:S82 / S82
页数:1
相关论文
共 50 条
  • [1] PI3K/Akt Pathway: A Potential Therapeutic Target for Chronic Pain
    Chen, Shu-Ping
    Zhou, Ya-Qun
    Liu, Dai-Qiang
    Zhang, Wen
    Manyande, Anne
    Guan, Xue-Hai
    Tian, Yu-Ke
    Ye, Da-Wei
    Omar, Deeq Mohamed
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (12) : 1860 - 1868
  • [2] PI3K/AKT Pathway as a Potential Therapeutic Target In Myelodysplastic Syndrome
    Rezende, Denise C.
    Pacheco, Lorena Zaida
    Pelloso, Luis Arthur F.
    Chauffaille, Maria L.
    Silva, Marcal C. A.
    Kimura, Elisa
    Casaes-Rodrigues, Rafael L.
    Segreto, Helena
    Yamamoto, Mihoko
    Maranhao Bahia Kerbauy, Daniella Marcia
    BLOOD, 2010, 116 (21) : 780 - 780
  • [3] The PI3K/Akt/mTOR Pathway as Therapeutic Target in Neuroblastoma
    Fulda, S.
    CURRENT CANCER DRUG TARGETS, 2009, 9 (06) : 729 - 737
  • [4] PI3K/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis
    Xiao Li Huang
    Jin Xu
    Xiao Hui Zhang
    Bo Yun Qiu
    Lan Peng
    Meng Zhang
    Hua Tian Gan
    Inflammation Research, 2011, 60 : 727 - 734
  • [5] PI3K/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis
    Huang, Xiao Li
    Xu, Jin
    Zhang, Xiao Hui
    Qiu, Bo Yun
    Peng, Lan
    Zhang, Meng
    Gan, Hua Tian
    INFLAMMATION RESEARCH, 2011, 60 (08) : 727 - 734
  • [6] PI3K/Akt as a potential therapeutic target in AML.
    Hu, W
    Konopleva, M
    McCubrey, J
    Milella, M
    McQueen, T
    Zhao, SR
    Andreeff, M
    BLOOD, 2001, 98 (11) : 103A - 103A
  • [7] The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
    Slomovitz, Brian M.
    Coleman, Robert L.
    CLINICAL CANCER RESEARCH, 2012, 18 (21) : 5856 - 5864
  • [8] The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer
    Mabuchi, Seiji
    Kuroda, Hiromasa
    Takahashi, Ryoko
    Sasano, Tomoyuki
    GYNECOLOGIC ONCOLOGY, 2015, 137 (01) : 173 - 179
  • [9] The PI3K/Akt pathway: a target for curcumin's therapeutic effects
    Aliyari, Mahdieh
    Ghoflchi, Sahar
    Hashemy, Seyed Isaac
    Hashemi, Seyedeh Fatemeh
    Reihani, Amirali
    Hosseini, Hossein
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2025, 24 (01)
  • [10] PI3K/AKT pathway: A potential therapeutic target in cerebral ischemia-reperfusion injury
    Han, Yiming
    Sun, Yu
    Peng, Shiyu
    Tang, Tingting
    Zhang, Beibei
    Yu, Ruonan
    Sun, Xiaoyan
    Guo, Shanshan
    Ma, Lijuan
    Li, Peng
    Yang, Pengfei
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 998